# Use of Nucleic Acid Tests on Pooled and Individual Samples From Donors of Whole Blood and Blood Components, Including Source Plasma, to Reduce the Risk of Transmission of Hepatitis B Virus:  Final Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/use-of-nucleic-acid-tests-on-pooled-and-individual-samples-from-donors-of-whole-blood-and-blood-components-including-source-plasma-to-reduce-the-risk-of-transmission-of-hepatitis-b-virus-final-guidance-for-industry/e8fb757d-ba0b-4dd1-9173-494e61da9b48

> FDA guidance document: Use of Nucleic Acid Tests on Pooled and Individual Samples From Donors of Whole Blood and Blood Components, Including Source Plasma, to Reduce the Risk of Transmission of Hepatitis B Virus:  Final Guidance for Industry. Issue date: October 01, 2012. Get complete insights and analysis.

---

## Details

- Title: Use of Nucleic Acid Tests on Pooled and Individual Samples From Donors of Whole Blood and Blood Components, Including Source Plasma, to Reduce the Risk of Transmission of Hepatitis B Virus:  Final Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2012-10-01
- Last Changed: 2019-06-15
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2011-D-0799">FDA-2011-D-0799</a>

## Related Documents

- [Clinical Considerations for Therapeutic Cancer Vaccines:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-considerations-for-therapeutic-cancer-vaccines-guidance-for-industry/e0e6e4e0-a883-4f71-bf37-784e147d32d9)
- [Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components Intended for Transfusion:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/use-of-nucleic-acid-tests-to-reduce-the-risk-of-transmission-of-west-nile-virus-from-donors-of-whole-blood-and-blood-components-intended-for-transfusion-guidance-for-industry/863d535f-7224-46e2-84c2-785caa4abcf3)
- [Nucleic Acid Testing  to Reduce the Possible Risk of Parvovirus B19 Transmission by Plasma-Derived Products:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/nucleic-acid-testing-to-reduce-the-possible-risk-of-parvovirus-b19-transmission-by-plasma-derived-products-guidance-for-industry/61270a0b-4323-4d9d-8dab-c2b9ea3aaf2c)